AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Role of anti-interleukin-2 receptor antibodies in kidney transplantation
Authors: Cibrik, DM Kaplan, B Meier-Kriesche, HU
Citation: Dm. Cibrik et al., Role of anti-interleukin-2 receptor antibodies in kidney transplantation, BIODRUGS, 15(10), 2001, pp. 655-666
Immunosuppression in elderly renal transplant recipients - Are current regimens too aggressive?
Authors: Meier-Kriesche, HU Kaplan, B
Citation: Hu. Meier-kriesche et B. Kaplan, Immunosuppression in elderly renal transplant recipients - Are current regimens too aggressive?, DRUG AGING, 18(10), 2001, pp. 751-759
Survival improvement among patients with end-stage renal disease: Trends over time for transplant recipients and wait-listed patients
Authors: Meier-Kriesche, HU Ojo, AO Port, FK Arndorfer, JA Cibrik, DM Kaplan, B
Citation: Hu. Meier-kriesche et al., Survival improvement among patients with end-stage renal disease: Trends over time for transplant recipients and wait-listed patients, J AM S NEPH, 12(6), 2001, pp. 1293-1296
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates
Authors: Ojo, AO Hanson, JA Meier-Kriesche, HU Okechukwu, CN Wolfe, RA Leichtman, AB Agodoa, LY Kaplan, B Port, FK
Citation: Ao. Ojo et al., Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates, J AM S NEPH, 12(3), 2001, pp. 589-597
Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation (vol 15, pg 2, 2000)
Authors: Portman, RJ Meier-Kriesche, HU Swinford, R Brannan, P Kahan, BD
Citation: Rj. Portman et al., Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation (vol 15, pg 2, 2000), PED NEPHROL, 16(3), 2001, pp. 309-309
Removal of Basiliximab by plasmapheresis
Authors: Okechukwu, CN Meier-Kriesche, HU Armstrong, D Campbell, D Gerbeau, C Kaplan, B
Citation: Cn. Okechukwu et al., Removal of Basiliximab by plasmapheresis, AM J KIDNEY, 37(1), 2001, pp. NIL_111-NIL_113
Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation
Authors: Meier-Kriesche, HU Gitomer, J Finkel, K DuBose, T
Citation: Hu. Meier-kriesche et al., Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation, CRIT CARE M, 29(4), 2001, pp. 748-752
Exponentially increased risk of infectious death in older renal transplantrecipients
Authors: Meier-Kriesche, HU Ojo, AO Hanson, JA Kaplan, B
Citation: Hu. Meier-kriesche et al., Exponentially increased risk of infectious death in older renal transplantrecipients, KIDNEY INT, 59(4), 2001, pp. 1539-1543
Mycophenolate mofetil decreases the risk for chronic renal allograft failure
Authors: Meier-Kriesche, HU Ojo, AO Arndorfer, JA Magee, JC Cibrik, DM Leichtman, AB Campbell, DA Kaplan, B
Citation: Hu. Meier-kriesche et al., Mycophenolate mofetil decreases the risk for chronic renal allograft failure, TRANSPLAN P, 33(1-2), 2001, pp. 1005-1006
Recipient age as an independent risk factor for chronic renal allograft failure
Authors: Meier-Kriesche, HU Ojo, AO Arndorfer, JA Port, FK Magee, JC Leichtman, AB Punch, JD Kaplan, B
Citation: Hu. Meier-kriesche et al., Recipient age as an independent risk factor for chronic renal allograft failure, TRANSPLAN P, 33(1-2), 2001, pp. 1113-1114
Time to first graft loss as a risk factor for second renal allograft loss
Authors: Arndorfer, JA Meier-Kriesche, HU Ojo, AO Gruber, SA Cibrik, DM Lake, KD Kaplan, B Leichtman, AB
Citation: Ja. Arndorfer et al., Time to first graft loss as a risk factor for second renal allograft loss, TRANSPLAN P, 33(1-2), 2001, pp. 1188-1189
Need for individualized immunosuppression in elderly renal transplant recipients
Authors: Meier-Kriesche, HU Ojo, AO Arndorfer, JA Leichtman, AB Lake, K Cibrik, DM Punch, JD Armstrong, DR Kaplan, B
Citation: Hu. Meier-kriesche et al., Need for individualized immunosuppression in elderly renal transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1190-1191
Deleterious effect of waiting time on renal transplant outcome
Authors: Meier-Kriesche, HU Port, FK Ojo, AO Leichtman, AB Rudich, SM Arndorfer, JA Punch, JD Kaplan, B
Citation: Hu. Meier-kriesche et al., Deleterious effect of waiting time on renal transplant outcome, TRANSPLAN P, 33(1-2), 2001, pp. 1204-1206
Differences in etiology for graft loss in female renal transplant recipients
Authors: Meier-Kriesche, HU Ojo, AO Leavey, SF Cibrik, DM Arndorfer, JA Leichtman, AB Punch, JD Armstrong, DR Kaplan, B
Citation: Hu. Meier-kriesche et al., Differences in etiology for graft loss in female renal transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1288-1290
Long-term benefit of kidney-pancreas transplants in Type 1 diabetics
Authors: Ojo, AO Meier-Kriesche, HU Arndorfer, JA Leichtman, AB Magee, JC Cibrik, DM Wolfe, RA Port, FK Agodoa, L Kaufman, DB Kaplan, B
Citation: Ao. Ojo et al., Long-term benefit of kidney-pancreas transplants in Type 1 diabetics, TRANSPLAN P, 33(1-2), 2001, pp. 1670-1672
Hypercoagulable states in renal transplant candidates: Impact of anticoagulation upon incidence of renal allograft thrombosis
Authors: Friedman, GS Meier-Kriesche, HU Kaplan, B Mathis, AS Bonomini, L Shah, N DeFranco, P Jacobs, M Mulgaonkar, S Geffner, S Lyman, N Paraan, C Walsh, C Belizaire, W Tshibaka, M
Citation: Gs. Friedman et al., Hypercoagulable states in renal transplant candidates: Impact of anticoagulation upon incidence of renal allograft thrombosis, TRANSPLANT, 72(6), 2001, pp. 1073-1078
Hepatitis C antibody status and outcomes in renal transplant recipients
Authors: Meier-Kriesche, HU Ojo, AO Hanson, JA Kaplan, B
Citation: Hu. Meier-kriesche et al., Hepatitis C antibody status and outcomes in renal transplant recipients, TRANSPLANT, 72(2), 2001, pp. 241-244
Interaction of mycophenolate mofetil and HLA matching on renal allograft survival
Authors: Meier-Kriesche, HU Ojo, AO Leichtman, AB Magee, JC Rudich, SM Hanson, JA Cibrik, DM Kaplan, B
Citation: Hu. Meier-kriesche et al., Interaction of mycophenolate mofetil and HLA matching on renal allograft survival, TRANSPLANT, 71(3), 2001, pp. 398-401
Gender differences in the risk for chronic renal allograft failure
Authors: Meier-Kriesche, HU Ojo, AO Leavey, SF Hanson, JA Leichtman, AB Magee, JC Cibrik, DM Kaplan, B
Citation: Hu. Meier-kriesche et al., Gender differences in the risk for chronic renal allograft failure, TRANSPLANT, 71(3), 2001, pp. 429-432
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival
Authors: Ojo, AO Meier-Kriesche, HU Hanson, JA Leichtman, A Magee, JC Cibrik, D Wolfe, RA Port, FK Agodoa, L Kaufman, DB Kaplan, B
Citation: Ao. Ojo et al., The impact of simultaneous pancreas-kidney transplantation on long-term patient survival, TRANSPLANT, 71(1), 2001, pp. 82-90
Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients
Authors: Meier-Kriesche, HU Ojo, AO Leichtman, AB Punch, JD Hanson, JA Cibrik, DM Kaplan, B
Citation: Hu. Meier-kriesche et al., Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients, J AM S NEPH, 11(12), 2000, pp. 2366-2370
Efficacy of Daclizumab in an African-American and Hispanic renal transplant population
Authors: Meier-Kriesche, HU Palenkar, SS Friedman, GS Mulgaonkar, SP Goldblat, MV Kaplan, B
Citation: Hu. Meier-kriesche et al., Efficacy of Daclizumab in an African-American and Hispanic renal transplant population, TRANSPLAN I, 13(2), 2000, pp. 142-145
Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation
Authors: Portman, RJ Meier-Kriesche, HU Swinford, R Brannan, P Kahan, BD
Citation: Rj. Portman et al., Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation, PED NEPHROL, 15(1-2), 2000, pp. 2-6
The effect of Daclizumab in a high-risk renal transplant population
Authors: Meier-Kriesche, HU Kaza, H Palekar, SS Friedman, GS Mulgaonkar, SP Ojo, AO Kaplan, B
Citation: Hu. Meier-kriesche et al., The effect of Daclizumab in a high-risk renal transplant population, CLIN TRANSP, 14(5), 2000, pp. 509-513
Pharmacokinetics of mycophenolic acid in renal insufficiency
Authors: Meier-Kriesche, HU Shaw, LM Korecka, M Kaplan, B
Citation: Hu. Meier-kriesche et al., Pharmacokinetics of mycophenolic acid in renal insufficiency, THER DRUG M, 22(1), 2000, pp. 27-30
Risultati: 1-25 | 26-43